BioCentury
ARTICLE | Company News

Prima, Xencor deal

September 12, 2005 7:00 AM UTC

PRR's Arthron Pty Ltd. subsidiary granted to Xencor a non-exclusive two-year license to Fc receptor technology for internal research. Arthron will receive an upfront fee and an annual license fee. Xen...